Mashup Score: 0 MDedge FDA approves setmelanotide for obesity in Bardet-Biedl syndrome - The FDA cleared setmelanotide (Imcivree) for people age 6 and older with obesity due to a rare genetic 1539985129686405120 MDEdge The FDA has approved a supplemental indication for setmelanotide injection for chronic weight management in adults and pediatric patients with obesity due to Bardet-Biedl Syndrome. https://t.co/3n1RCYMwCq - view on twitter Read the full article here See more from MDEdge Share this article × facebook twitter email https://mashupmd.com/fda-approves-setmelanotide-for-obesity-in-bardet-biedl-syndrome-2/ Copy Link
Reuters China's Clover says its COVID booster shot candidate lifts antibody against Omicron Reuters Health
www.medicalnewstoday.com Supreme Court overturns Roe V. Wade, ending federal abortion rights #RoeVsWade Medical News Today
PracticeUpdate Impact of a Third Anti–SARS-CoV-2 mRNA Dose on Seropositivity in Patients With Lym... PracticeUpdate
Evidently Cochrane Cataract surgery: a quick look - Evidently Cochrane #Cataract The Cochrane Library
NPR.org He and his wife both got cataract surgery. His bill was 20 times higher than hers NPR Health News
NPR.org In N.Y.'s primary, 2 Democrats and 4 Republicans are running to oust Gov. Hochul NPR Health News
YouTube Using Stories in Health and Physical Activity Promotion - Dr Joshua Pate (Pt1) #animation #behaviorchange Physical Activity Researcher Podcast 🎙️
The FDA has approved a supplemental indication for setmelanotide injection for chronic weight management in adults and pediatric patients with obesity due to Bardet-Biedl Syndrome. https://t.co/3n1RCYMwCq - view on twitter